We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck to further study Keytruda in prostate cancer after early successMerck & Co Inc said on Thursday it was launching three late-stage studies for its cancer immunotherapy Keytruda as a combination treatment for ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Merck, Pfizer drug combo extends kidney cancer survival: studyA combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Merck to further study Keytruda in prostate cancer after early successMerck & Co Inc said on Thursday it was launching three late-stage studies for its cancer immunotherapy Keytruda as a combination treatment for ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Merck, Pfizer drug combo extends kidney cancer survival: studyA combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Liver cancer top cause of cancer death among men in their 40s and 50sThe statistics about hepatocellular carcinoma (HCC), the most common type of primary liver cancer, are troubling. Eighty per cent of all the cases in the world occur in Asia, and it has come to be known as an 'Asian disease'. HCC is the third most common cause of...
Source: thenewpaper - 🏆 7. / 63 Read more »
Intercept's drug for patients with liver fibrosis due to NASH meets main goalREUTERS: Intercept Pharmaceuticals Inc said on Tuesday its treatment testing patients with liver fibrosis due to nonalcoholic steatohepatitis ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Nektar, Bristol combo drug shows signs of tumor reduction in bladder cancer patientsNektar Therapeutics said on Friday some patients with advanced bladder cancer treated with a combination of its experimental treatment and ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Joining a clinical trial is too hard for many cancer patients(Reuters Health) - Only a small fraction of cancer patients volunteer for clinical trials. The reason, a new study suggests, is not that they ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »